Law

The Justice Department announced that an eye practice and its physician owner agreed to pay $350,000 to resolve allegations that they submitted false claims to Medicare. According to the announcement, the matter involves healthcare billing enforcement under the False Claims Act. The case is a smaller but distinct Medicare fraud settlement compared with previously covered large-scale healthcare fraud and kickback matters.

DOJ announced a $541.5 million settlement with The Villages Health System LLC to resolve False Claims Act allegations related to diagnosis coding. The government alleged unsupported diagnoses inflated Medicare Advantage payments, raising compliance and documentation concerns. The settlement is notable for its size and for its implications for coding accuracy, reimbursement oversight, and standards affecting patient care records.

DOJ announced that Veloxis Pharmaceuticals agreed to pay more than $46 million to resolve criminal and civil allegations tied to kickback schemes involving prescriptions for a transplant drug. The resolution centers on alleged unlawful payments and federal healthcare program implications, with DOJ framing the case around program integrity and patient safety. The case underscores continued enforcement against pharmaceutical marketing practices that may influence prescribing.

DOJ announced a nationwide healthcare fraud enforcement action charging 455 defendants in connection with more than $6.5 billion in alleged fraud. The announcement spans schemes involving healthcare fraud, opioid-related conduct, provider exclusions, and allegations of patient harm. It reflects the scale of federal enforcement and the legal risks facing providers, executives, and intermediaries across multiple parts of the healthcare system.

The Justice Department announced a proposed settlement requiring OhioHealth to stop using contract terms alleged to restrict competition. According to DOJ, the challenged terms raised healthcare costs for Ohio patients and employers by limiting insurers' ability to steer patients to lower-cost providers. The matter highlights antitrust scrutiny of healthcare contracting practices with downstream effects on prices and patient choice.

A U.S. Attorney's Office announced a $15.2 million civil judgment resolving Medicaid fraud allegations involving operators of a children's day treatment program. The matter involves behavioral health services for children and includes a corporate integrity agreement and compliance obligations. The resolution highlights legal and oversight risks in pediatric Medicaid-funded care and the importance of program compliance.

DOJ announced that the National Partnership of Insurance Brokers and its former subsidiary agreed to pay more than $135 million to resolve allegations involving an Affordable Care Act enrollment fraud scheme. The case concerns alleged misconduct affecting consumers and federal enrollment processes, with particular relevance to protections for vulnerable enrollees. It illustrates legal exposure for entities involved in insurance marketing and enrollment assistance.